Diabetes patients face life-threatening insulin shortage in Gaza
The headline indicates a shortage of insulin, a critical medical input, affecting patient access in Gaza.
Source →The trace
How it reaches your house.
Starting from Insulin, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
First impact
Recombinant Insulin API (Bulk Drug Substance) →Shortage riskRecombinant insulin API is a critical precursor to insulin, and the graph gives this dependency a 0.98 strength, so a shortage here directly tightens insulin supply.
99% confidenceRecombinant Insulin API (Bulk Drug Substance) →Shortage riskPeople with diabetes in the Gaza Strip
The cited report says insulin shortages in the Gaza Strip put thousands of people at growing risk of life-threatening complications, so patient access is directly constrained.
“The International Diabetes Federation estimates that an insulin shortage in the West Bank and the Gaza Strip puts about 11,000 people at growing risk of life-threatening complications.”
88% confidenceCited →Insulin Delivery Devices (Pen Injectors & Insulin Pumps) →Shortage risk
Where it lands
What you buy, and what you own.
Goods you buy
Insulin
Companies you may own
No named companies on this path.
Tap a company to see what it told the SEC could break it.
In the MyPRIA app, this is checked against your own holdings.